SEVERE MYOCARDITIS AS A COMPLICATION OF A NOVEL DUAL IMMUNOTHERAPY TREATMENT IN A PATIENT WITH ESOPHAGEAL CANCER
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2018)
摘要
Immunotherapy has been introduced into the treatment of numerous cancers with impressive survival benefits. However, several immune-related adverse events (irAEs) have been reported, including a spectrum of myocardial toxicities in 1-3% of patients, for which there is a need for increased awareness
更多查看译文
关键词
esophageal cancer,immunotherapy
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要